FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

BofA’s chief equity strategist, Michael Hartnett, noted that Wall Street is “sensibly rotating from AI spenders to beneficiaries, services to manufacturing, U.S. exceptionalism to global rebalancing.” ...

Message from CEO IBT's plan to apply for marketing approval in the US through a so-called accelerated application remains unchanged. The development program for IBP-9414 is "Breakthrough Designated," ...

Proposed maritime bans and shadow fleet interceptions threaten a key revenue stream Moscow relies on to fund its war in ...

December 2025• Net revenue was SEK 2,483 million (2,687).• Organic growth was -1.9 percent (0.8).• Operating profit amounted to SEK 83m (106).• ...